SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ASTM-AASTROM BIOSCIENCES: STEM CELL RESEARCH -- Ignore unavailable to you. Want to Upgrade?


To: RickT who wrote (590)3/8/1999 12:50:00 AM
From: William Hayden  Read Replies (1) | Respond to of 1084
 
Yes it was on NBC, but they did not mention ASTM by name. It was a good piece about using stem cell transplants for stopping Multiple Sclerosis degeneration. The test subjects were not degenerating any further after the transplants, so the earlier the treatment the better. Also they were testing it on a few other degenerative diseases and mentioned that it was a good candidate for using on cancer. All in all it was a positive story.



To: RickT who wrote (590)3/20/1999 12:42:00 AM
From: JEB  Respond to of 1084
 
I guess we'll have to call off any potential revolt:

Message 8390277

Looks like Tobin is spoken for and oh how the analysts love him.

We're a day late, and a dollar short!